CalmWave is a healthcare technology start-up that addresses alarm fatigue. It is especially in the Intensive Care Units and has secured $5.25 million in funding, with the lead investor being Third Prime. They have clearly outlined that the funds will be used to expand the market penetration as well as improve sales to key healthcare players.
Addressing Alarm Fatigue
These alarms can lead to alarm fatigue, which is a major problem in ICUs today due to frequent alarms that are not even actionable. These are sustaining alerts, which account for 80-99% of all the alarms, disrupt patient care, and cause outcomes such as ICU delirium. These are the objectives of the existing system. CalmWave’s solution will also seek to reduce these kinds of non-actional alarms greatly.
How CalmWave Works?
CalmWave has designed the platform to gather patient information through the signs and interventions. This system powered by artificial intelligence offers precise advice to reduce the distraction caused by too many alarms. Application of these recommendations will help increase the quality of the clinical work environment as well as the care given to the patients.
Investor Support
The latest financing process, which also involved other big shots such as Catalyst by Wellstar and Silver Circle, also showed the increased market opportunity of CalmWave’s innovation. Co-founder of Third Prime Keith Hamlin reiterated the company’s leadership and the innovative solutions it offers to improve the operational aspects of hospitals.
Thus, with this new source of funds, the company is prepared to move to the next level of growth and deliver its new and promising technology to even more hospitals to ultimately better the lives of the patients and the overall efficiency of the ICU units.
